2026 NPPES data Endocrinology, Diabetes & Metabolism Physician NPI 1851507586 MD, PHD
Verify on CMS →

OSSAMA LASHIN, MD, PHD

Endocrinology, Diabetes & Metabolism Physician in LORAIN, Ohio. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
1K
Medicare Part D claims · 281 beneficiaries · Endocrinology, Diabetes & Metabolism Physician avg: 3K
Generic prescribing
67%
generic claims · 33% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$6.4K
32 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

OSSAMA LASHIN, MD, PHD filed 1,006 Medicare Part D claims in 2023 as a Endocrinology, Diabetes & Metabolism Physician in LORAIN, Ohio, prescribing 67% generic.

1K
Part D claims, 2023
67%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

OSSAMA LASHIN, MD, PHD's Medicare Part D volume vs every U.S. prescriber

Total Medicare Part D claims, 2023 — across all CMS prescribers nationally

1,006 Top 24% higher than 76% of 1,370,886 prescribers

0–200: 670,926 prescribers (49%). Below this entry. 200–400: 182,923 prescribers (13%). Below this entry. 400–600: 90,619 prescribers (7%). Below this entry. 600–800: 56,224 prescribers (4%). Below this entry. 800–1,000: 40,919 prescribers (3%). Below this entry. 1,000–1,200: 31,827 prescribers (2%). This entry sits in this band. 1,200–1,400: 26,224 prescribers (2%). Above this entry. 1,400–1,600: 21,710 prescribers (2%). Above this entry. 1,600–1,800: 19,072 prescribers (1%). Above this entry. 1,800–2,000: 16,451 prescribers (1%). Above this entry. 2,000–2,200: 213,991 prescribers (16%). Above this entry. This provider 0 2K+ every Part D prescriber (claims/yr), bucketed by value

Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Medicare Part D Prescriber Public Use File · 2023

Board certification likely (heuristic — not verified)

OSSAMA LASHIN, MD, PHD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about OSSAMA LASHIN, MD, PHD?

Quality data not reported

NPI registry status

Active

Issued 05/16/2007

NPI 1851507586

Primary specialty

Endocrinology, Diabetes & Metabolism Physician

Mid-sized

7,852 US NPIs in this specialty

Medicare Part D claims

1,006 62% vs specialty avg

2023 prescription claims

Specialty avg: 2,639

Specialty distribution in Ohio

How Endocrinology, Diabetes & Metabolism Physician compares to other specialties among Ohio providers

Ohio providers

Endocrinology, Diabetes & Metabolism Physician share within Ohio

1. Endocrinology, Diabetes & Metabolism Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Endocrinology, Diabetes & Metabolism Physician share within Ohio

Specialty board-certification context

Estimated specialty board-certified rate — Endocrinology, Diabetes & Metabolism Physician (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Endocrinology, Diabetes & Metabolism Physician ABMS/AOA estimate

Est. board-certified rate (Endocrinology, Diabetes & Metabolism Physician) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Endocrinology, Diabetes & Metabolism Physician) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

OSSAMA LASHIN, MD, PHD appears in the CMS NPPES registry as a Endocrinology, Diabetes & Metabolism Physician provider holding MD, PHD credentials at 5700 COOPER FOSTER PARK RD., LORAIN, OH, 44053, with a listed phone of (440) 204-7400. NPI 1851507586 was issued on 05/16/2007. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what LASHIN most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 1,006 prescription claims written by this provider, covering 281 Medicare beneficiaries and totaling roughly $50K in drug spend, split 33% brand-name and 67% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Endocrinology, Diabetes & Metabolism Physician is a mid-sized specialty nationwide, with 7,852 enrolled providers across 54 states and an average of 2,639 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

5700 COOPER FOSTER PARK RD.
LORAIN, OH 44053

Provider Details

NPI 1851507586
Specialty Endocrinology, Diabetes & Metabolism Physician
Credentials MD, PHD
Gender Male
NPI Issued 05/16/2007

Hospital and facility affiliations

Facilities where OSSAMA LASHIN, MD, PHD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

CLEVELAND CLINIC
★★★★☆ 4/5
CLEVELAND, OH
Acute Care Hospitals
CMS CCN: 360180

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for OSSAMA LASHIN, MD, PHD. Source: openpaymentsdata.cms.gov.

Total received

$6.4K

Largest payer

Amgen Inc.

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — Ohio OMB 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~48K Ohio medical licensees in 2023 — they are NOT specific to OSSAMA LASHIN, MD, PHD. To verify OSSAMA LASHIN, MD, PHD's current license status, search the OMB public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

158
Total board actions, Ohio 2023
Across 154 cases
3.29
Actions per 1,000 licensees
Ohio statewide rate
probation
Most common action type
56 cases

OMB publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Ohio disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Above average

OSSAMA LASHIN, MD, PHD — brand share 33.0%
Specialty average (est.)

33% brand-name claims vs 67% generic, on 1,006 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

1,006
Total Claims
$50K
Total Drug Cost
281
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
2,570
Total Day Supply
76,874
Brand vs Generic
33% brand / 67% generic
Brand Drug Cost
$27K
Generic Drug Cost
$22K

Patient Demographics

Average Patient Age
72.0 years
Avg HCC Risk Score
1.14
Gender Split
73% female / 27% male
Age Distribution
<65: 30, 65-74: 146, 75-84: 90, 85+: 15

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What OSSAMA LASHIN, MD, PHD prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Levothyroxine Sodium
572
Synthroid
Levothyroxine Sodium
132
Methimazole
93
Liothyronine Sodium
45
Hydrocortisone
24
Cabergoline
17
Testosterone Cypionate
14
Metformin Hcl Er
Metformin Hcl
11
Armour Thyroid
"Thyroid
N/A

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Endocrinology, Diabetes & Metabolism Physician Overview

How OSSAMA LASHIN, MD, PHD fits within the Endocrinology, Diabetes & Metabolism Physician landscape nationally.

7,852
Endocrinology, Diabetes & Metabolism Physician Providers in US
54
States with Endocrinology, Diabetes & Metabolism Physician
2,639
Avg Claims per Provider

OSSAMA LASHIN, MD, PHD's 1,006 claims are below the specialty average of 2,639.

Nearby Endocrinology, Diabetes & Metabolism Physician Providers in Ohio

Other clinicians with the same primary specialty enrolled in Ohio, drawn from the same CMS NPPES roster as LASHIN.

Compare Endocrinology, Diabetes & Metabolism Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is OSSAMA LASHIN, MD, PHD's specialty?
OSSAMA LASHIN, MD, PHD specializes in Endocrinology, Diabetes & Metabolism Physician and practices in LORAIN, Ohio. Credentials: MD, PHD.
How much does OSSAMA LASHIN, MD, PHD prescribe under Medicare Part D?
In 2023, OSSAMA LASHIN, MD, PHD wrote 1,006 Medicare Part D claims totaling $50K in drug costs for 281 beneficiaries.
Where is OSSAMA LASHIN, MD, PHD located?
OSSAMA LASHIN, MD, PHD is located at 5700 COOPER FOSTER PARK RD., LORAIN, OH, 44053. Phone: (440) 204-7400.
What is OSSAMA LASHIN, MD, PHD's NPI number?
OSSAMA LASHIN, MD, PHD's National Provider Identifier (NPI) is 1851507586, issued on 05/16/2007.
Does OSSAMA LASHIN, MD, PHD prescribe more brand-name or generic drugs?
OSSAMA LASHIN, MD, PHD's prescribing is 33% brand-name and 67% generic drugs by claim count, with $27K in brand drug costs.
How many Endocrinology, Diabetes & Metabolism Physician providers are there in the US?
There are 7,852 Endocrinology, Diabetes & Metabolism Physician providers across 54 states in the US. The average Endocrinology, Diabetes & Metabolism Physician provider writes 2,639 Medicare Part D claims per year.
What drugs does OSSAMA LASHIN, MD, PHD prescribe most often?
Based on 2023 Medicare Part D data, OSSAMA LASHIN, MD, PHD's most frequently prescribed drugs include Levothyroxine Sodium, Synthroid, Methimazole. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does OSSAMA LASHIN, MD, PHD accept Medicare?
OSSAMA LASHIN, MD, PHD appears in CMS Medicare data with 1,006 Part D claims and 281 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify OSSAMA LASHIN, MD, PHD's credentials?
OSSAMA LASHIN, MD, PHD's NPI is 1851507586 with credentials MD, PHD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology